EFFICIENCY OF ESOMEPRAZOLE AS AN INITIAL THERAPY OF ESOPHAGITIS IN THE ELDERLY PATIENTS
- Authors: Maev I.V.1, Tsukanov V.V.1, Onuchina E.V.1, Butorin N.N.1, Bichurina T.B.1, Vasyutin A.V.1, Ayvazova RA1, Mayev IV1, Tsukanov VV1, Onuchina Y.V1, Butorin NN1, Bichurina TB1, Vasyutin AV1, Aivazova RA1
-
Affiliations:
- Issue: No 12 (2011)
- Pages: 93-95
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278948
- ID: 278948
Cite item
Full Text
Abstract
Keywords
About the authors
Igor' Veniaminovich Maev
Vladislav Vladimirovich Tsukanov
Elena Vladimirovna Onuchina
Nikolay Nikolaevich Butorin
Tat'yana Borisovna Bichurina
Aleksandr Viktorovich Vasyutin
R A Ayvazova
I V Mayev
V V Tsukanov
Ye V Onuchina
N N Butorin
T B Bichurina
A V Vasyutin
R A Aivazova
References
- Машарова А.А. Повышение эффективности и безопасности фармакотерапии ГЭРБ у пожилых // Клиническая геронтология 2005. № 9. С. 31-2.
- Pilotto A, Franceschi M, Leandro G, et al. Clinical features of reflux esophagitis in older people: a study of 840 consecutive patients. J Am Geriatr Soc 2006;54(5):1537-42.
- Vakil N, van Zanten S, Kahrilas P, et al. The Monreal Definition and Classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101(8):1900-20.
- Lundell LR, Dent J, Bennet JR. Endoscopic assessment of oesophagitis clinical and fuctional correlates and futher validation of Los Angeles classification. Gut 1999;45(2):72-180.
- Heikkila S. The Dougados Functional Index with the 5-point Likert scale is sensitive to change due to intensive physiotherapy and exercise in spondyloarthropathy. Clin Exp Rheumatol 2002;5(3):689-92.
- Richter JE, Kahrilas PJ, Johanson J, et al. Efficacy and safety of esomepazole compared with omeprazole in GERD patients with erosive esophagitis: a randomized controlled trial. Am J Gastroenterol 2001;96(3):656-65.
- Labenz J, Armstrong D, Lauritsen K, et al. A randomized comparative study of esomepazole 40 mg versus pantoprazole 40 mg for healing erosive esophagitis: the EXPO study. Aliment Pharmacol Ther 2005;21(6):739-46.
- Lauritsen K, Deviere J, Bigard MA, et al. Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther 2003;17(3):333-41.
- Edwards SJ, Lind T, Lundell L, et al. Systematic review: standard- and double-dose proton pump inhibitors for the healing of severe erosive oesophagitis - a mixed treatment comparison of randomized controlled trials. Aliment Pharmacol Ther 2009;30(6):547-56.